Cargando…
The Role of Concomitant Nrf2 Targeting and Stem Cell Therapy in Cerebrovascular Disease
Despite the reality that a death from cerebrovascular accident occurs every 3.5 min in the United States, there are few therapeutic options which are typically limited to a narrow window of opportunity in time for damage mitigation and recovery. Novel therapies have targeted pathological processes s...
Autores principales: | Gordon, Jonah, Lockard, Gavin, Monsour, Molly, Alayli, Adam, Borlongan, Cesario V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332234/ https://www.ncbi.nlm.nih.gov/pubmed/35892653 http://dx.doi.org/10.3390/antiox11081447 |
Ejemplares similares
-
Sequestration of Inflammation in Parkinson’s Disease via Stem Cell Therapy
por: Gordon, Jonah, et al.
Publicado: (2022) -
Mitochondria in Cell-Based Therapy for Stroke
por: Monsour, Molly, et al.
Publicado: (2023) -
Stem Cells: Recent Developments Redefining Epilepsy
Therapy
por: Alayli, Adam, et al.
Publicado: (2023) -
Probing Interleukin-6 in Stroke Pathology and Neural Stem Cell Transplantation
por: Lockard, Gavin Miles, et al.
Publicado: (2022) -
Minor Changes for a Major Impact: A Review of Epigenetic Modifications in Cell-Based Therapies for Stroke
por: Monsour, Molly, et al.
Publicado: (2022)